Bacterial colonization, probiotics, and clinical disease - 09/08/11
Résumé |
With the emergence of the hygiene hypothesis, science has begun to reconsider the role of bacteria in host health. Data from germ-free animals and clinical studies support the idea that the colonization of intestinal flora and bacteria-host cross-talk play pivotal roles in the development of the mucosal immune system. Here we discuss the role of commensal colonizing bacteria and toll-like receptor/nucleotide-binding oligomerization domain (TLR/NOD) receptors in the regulation of intestinal immunity and the relationship between TLR/NOD and immune-mediated disease, especially inflammatory bowel disease. We also explore the mechanism of the induction of immune hyporesposiveness by gut epithelial cells interacting with commensal bacteria. A better understanding of bacteria-host interactions will help provide a rational basis for using probiotics as a dietary supplement to prevent and treat disease in the future.
Le texte complet de cet article est disponible en PDF.Abbreviations : CAMP, CARD, CD, DC, IBD, IEC, IL, LPS, NOD, PAMP, Th1, Th2, TLR, TNF, Treg
Plan
Dr. Walker is a recipient of a Bristol-Myers Squibb–Mead Johnson Unrestricted Nutrition Research Grant. Mead Johnson sponsored the symposium and provided an honorarium for conference attendance, presentation of the paper, and submission of a manuscript. The authors are entirely and exclusively responsible for its content. |
Vol 149 - N° 5S
P. S107-S114 - novembre 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?